Suraksha Diagnostic IPO Subscribed 1.27 Times: All You Need to Know
Introduction to Suraksha Diagnostic IPO Subscription
Suraksha Diagnostic IPO has attracted considerable interest from investors, with the subscription closing at 1.27 times on December 3, 2024. This IPO is an Offer-for-Sale (OFS) worth ₹846.25 crore, providing a chance to invest in the growing diagnostic services sector. In this article, we will explain the Suraksha Diagnostic IPO subscription. We will also show how to check your allotment status and inform you about the expected listing date.
What is the Suraksha Diagnostic IPO Subscription Rate?
- Total Subscription: 1.27 times
- Retail Subscription: 95%
- NII (Non-Institutional Investors) Subscription: 1.4 times
- QIB (Qualified Institutional Buyers) Subscription: 1.74 times
Key IPO Details for Suraksha Diagnostic
| Details | Information |
|---|---|
| IPO Size | ₹846.25 crore (OFS) |
| Price Band | ₹420 to ₹441 per share |
| Minimum Investment | ₹14,994 (34 shares per lot) |
| Retail Portion Subscription | 95% |
| Listing Date | December 6, 2024 (Tentative) |
Steps to Check Suraksha Diagnostic IPO Allotment Status
After the IPO subscription ends, investors eagerly await the share allotment. Here’s how you can check your Suraksha Diagnostic IPO allotment status:
How to Check IPO Allotment on NSE
- Visit: NSE IPO Status
- Log in with your credentials or create an account if you are a new user.
- Select Suraksha Diagnostic Limited from the dropdown menu.
- Enter your PAN and Application Number.
- Click Submit after completing the CAPTCHA.
How to Check IPO Allotment on Kfin Technologies
- Visit: Kfin IPO Status.
- Choose a server from the options provided.
- Select Suraksha Diagnostic Limited from the IPO list.
- Enter your PAN, Application Number, or DP/Client ID.
- Click Submit to see your allotment status.
Expected Timeline for Suraksha Diagnostic IPO
- Allotment Status Finalized: December 4, 2024
- Refund Initiation and Share Transfer: December 5, 2024
- Listing on NSE & BSE: December 6, 2024
Why Was Suraksha Diagnostic IPO Subscription Popular?
The Suraksha Diagnostic IPO generated interest due to its strong presence in the diagnostic services industry. It operates across key regions. Investors see potential in the company’s growth and its ability to expand its customer base. The IPO’s competitive pricing and strong subscription from institutional investors (QIBs) further added to its appeal.
FAQs: Suraksha Diagnostic IPO Subscription and Allotment
1. What is the final subscription rate for Suraksha Diagnostic IPO?
The Suraksha Diagnostic IPO was subscribed 1.27 times on its final day of subscription.
2. How do I check my Suraksha Diagnostic IPO allotment status?
You can check your allotment status on the NSE or Kfin Technologies website by entering your PAN or application number.
3. When will the Suraksha Diagnostic IPO be listed?
The Suraksha Diagnostic IPO is expected to be listed on December 6, 2024.
4. What is the price range for Suraksha Diagnostic IPO?
The price range for Suraksha Diagnostic IPO was set between ₹420 to ₹441 per share.
5. How many shares do I need to apply for in the Suraksha Diagnostic IPO?
The smallest application size for retail investors is 34 shares, totaling ₹14,994.
Conclusion
The Suraksha Diagnostic IPO attracted solid subscription from both retail and institutional investors, signaling strong market confidence. Investors can now look ahead to checking their allotment status and preparing for the listing date on December 6, 2024. Whether you’re a new investor, the Suraksha Diagnostic IPO offers an exciting opportunity. If you are a seasoned market participant, it presents a chance. You can tap into the growing healthcare and diagnostic services sector.
For more information on IPOs and how to invest, feel free to explore extra resources.
This post is for informational purposes only.Invest responsibly.No guarantees of results. Seek professional guidance before investing.Consult experts for personalized advice.AI-assisted content, editorially reviewed.See our terms for details. Follows Google policies.Not affiliated with Investopedia.com. investopedia.co.in Independent site.
